With the need for growth and untragenyx pipeline there isn't another biotech with the opporunities in rare diseases as untrageyx which is the reason that the stock held it's own on friday- this stock will be $200+ very soon
All of the big boys have buys and outperforms with all targets from 30-40 pps- hopefully they covered because axon will be at $30 by end of the year
Big volume and snapping up big offers like i have never seen before. we are on the verge of something huge?
Should see $40 in no time and selling on news is really not unexpected. buy now